Katsuyuki Takahashi

Pretreatment Platelet Count and Neutrophil/Lymphocyte Ratio Are Predictive Markers for Carboplatin Plus Pemetrexed Therapy-induced Thrombocytopenia

H. Kaneda, T. Kawaguchi, K. Nagayama, 2021, AntiCancer Research.

Association between the Co-administration of Histamine H2 Receptor Antagonists and the Effectiveness of Capecitabine in Patients with Colorectal Cancer: Propensity Score Analysis

R. Uozumi, H. Hashimoto, Y. Hosokawa, 2022, Journal of Cancer.

Establishment of nedaplatin safety dose formula based on renal function for combination chemotherapy with nedaplatin and 5-fluorouracil in patients with esophageal cancer

M. Ohira, K. Muguruma, K. Nagayama, 2021, International Journal of Clinical Oncology.

The Cyclin-Dependent Kinase 4/6 Inhibitor Abemaciclib Is Tolerated Better than Palbociclib by Advanced Breast Cancer Patients with High Serum Albumin Levels.

T. Morisaki, S. Noda, S. Kashiwagi, 2022, Biological & pharmaceutical bulletin.

Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study

R. Uozumi, H. Hashimoto, Y. Hosokawa, 2022, Scientific Reports.

Long‐term use of foscarnet is associated with an increased incidence of acute kidney injury in hematopoietic stem cell transplant patients: A retrospective observational study

M. Hino, S. Nanno, K. Nagayama, 2022, Transplant infectious disease : an official journal of the Transplantation Society.

Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study

Kaori Ito, Shota Suzuki, H. Miyata, 2023, International Journal of Clinical Oncology.

A Research Survey on the Knowledge and Consciousness of Doping among High School Athletes and their Coaches

H. Iwao, Yasutaka Nakamura, K. Nagayama, 2013 .

Analysis of Factors Influencing Acute Kidney Injury with Docetaxel, Cisplatin, and 5-fluorouracil in Patients with Esophageal Cancer

K. Nagayama, Masaya Takahashi, Katsuyuki Takahashi, 2022, Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences).